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Background: Urogenital schistosomiasis (UGS) causes inflammation and fibrosis of the urinary tract. In 
resource-limited settings, novel diagnosticaffordable tools are needed for morbidity assessment in clinical 
care are needed. Point-of-care ultrasound has not yet been investigated on the detection ofvalidated for 
UGS-related pathology. 
Methods: We developed a protocol for Focused Assessment with Sonography for Urinary Schistosomiasis 
(FASUS), assessing pathology of the bladder wall, ureters and kidneys. Following standardized training, two 
clinicians performed FASUS on children and adults with haematuria in Lambaréné, Gabon. Recorded 
ultrasound clips were remotely reviewed by two ultrasound experts as diagnostic reference. 
Results: In 2015 and 2016, FASUS scans were performed in 118 patients. Image quality was sufficient in 
90% of bladder views and more than 97% of kidney views. UGS-compatible pathology was detected in 
51/118 (43%) by the operator and in 46/107 (43%) by the experts among baseline scans of sufficient quality. 
Inter-rater agreement between operators and experts was very good (κ > 0.8) for hydronephrosis and good 
(κ > 0.6) for bladder wall thickening. 
Conclusions: FASUS is a promising bedside clinical, point- of- care diagnostic tool with good diagnostic 
accuracyfor detecting USG-related renal tract morbidity in symptomatic patients in this pilot assessment. 
Based on data fromlarger validation studies larger cohorts examined with FASUS, appropriate diagnostic 
and therapeutic algorithms for the use of FASUS should be established. 
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Urogenital schistosomiasis (UGS), a waterborne disabling parasitic neglected tropical disease, affects an 
estimated 112 million people, with more than 400 million people at risk.1, 2 Chronic infection and its sequelae 
cause substantial morbidity reported mainly, but not exclusively, in school-aged children and young adults.3, 4 
UGS-related pathology comprises bladder wall thickening, distal ureteric wall thickening, and in an advanced 
stage also upper urinary tract obstruction and renal failure,5 as well as squamous cell carcinoma of the 
bladder.6 If treated early in the course of disease, a certain proportion of the pathological changes in the 
urinary tract are reversible.3 In patients with irreversible damage, options for treatment will depend on the 
type of damage and available treatment.   
In most high and moderate-prevalence areas the only available diagnostic tools are detection of haematuria 
by urine dipstick and direct parasitological examination of the urine. These tools, as well as novel methods 
such as detection of specific antibodies, antigens or genetic material,7-9 can confirm infection but detect 
neither anatomical changes due to the infection nor sequelae after treatment. 
In prevalence surveys, uUltrasound has long been established as is a n well-documented, effective imaging 
tool to assess urinary tract morbidity in UGS and to monitor treatment response, with results comparable to 
more invasive methods such as cystoscopy.10 Being a test for morbidity and not active infection, ultrasound 
does not replace but complement parasitological tests.  
In 1996 the World Health Organization (WHO) published a guideline standardised protocol for the 
ultrasonographic assessment of schistosomiasis-related morbidity, commonly known as the Niamey 
protocol.,11 This protocol resulted from an expert meeting collating available knowledge and experience on 
previously published standardized protocolsHowever, this protocol is specifically designed  developed for 
application in large-scale control programs and not .for diagnosis in the clinical setting. Suggested 
evaluations of thisIt landmark document  for ultrasound in schistosomiasis  and requireincludes a ing detailed 
and relatively complex grading system, which is less relevant to clinical application. relatively advanced 
ultrasound skills due to its complexity and recommendations for improvement have been formulated12. 
Contrary to widespread experience of using ultrasound in prevalence surveysTo date, ultrasound it has not 
been widely used or validated in for routine patient care in schistosomiasis endemic areas. In addition, 
prevalence surveys mostly rely on operators with professional ultrasound training. In many clinical settings, 
this expertise is lacking..  
Point-of-care ultrasound (POCUS)OCUS has been successfully implemented for various other indications in 
tropical medicine, e.g. HIV-associated tuberculosis and echinococcosis.13  
The aim of our study was to pilot a POCUS protocol for detection of UGS-related renal tract morbidity in 
symptomatic patients, to evaluate practical feasibility and evaluate the performance of operators with limited 
training, using low cost equipment.  
 
Now that point-of-care ultrasound (POCUS) is expanding rapidly in resource constrained settings, a 
simplified and more pragmatic protocol to identify relevant pathology may be of value to establish the clinical 




Being a test for morbidity and not active infection, such a protocol will not replace but complement 
parasitological tests. POCUS has been successfully implemented for various other indications in tropical 
medicine, e.g. HIV-associated tuberculosis and echinococcosis.13 
The aim of our study was to develop pilot a Point of care ultrasound ( POCUSPOCUS) protocol for detection 
of UGS-related renal tract morbidity in symptomatic patients, y and to evaluate practicalits feasibility and 
evaluate the performance of operators withaccuracy after limited training, using low cost equipment of 




This study was conducted at the Centre de Recherches Médicales de Lambaréné (CERMEL) located in the 
semi-rural setting of Lambaréné, Gabon, where UGS is highly prevalent.14-19 It was part of a larger study, 
which additionally assessed epidemiological aspects as well as immunological and metabolomic aspects of 
UGS; these will be reported separately. In summary, this study comprised the following parts:Procedures 
relevant for the pilot assessment of our POCUS protocol were A) development of a POCUS scan n 
ultrasound protocol for point-of-care detection of UGS-related pathology; B) training of two operators on this 
protocol; C) evaluation of the diagnostic accuracy of this protocol in patients with UGS withPOCUS 
operators, using remote expert image review as reference. D) Comparing ultrasound findings with 
parasitology test results. A portable low-cost ultrasound device (MINDRAY Digital Ultrasonic Diagnostic 
Imaging System model DP-10) with a curved array transducer (MINDRAY model 35C50EB) was used for 
training as well as for study procedures. 
Protocol development 
A simple and easy-to-learn protocol was designed by the study team, selecting clinically relevant criteria  
adapted from the Niamey protocol, which . This WHO guideline provides instructionsstandards for the 
evaluation of the urinary bladder (shape, bladder wall thickening, irregularities and polyps), ureters (ureteral 
dilation), renal pelvis (degree of hydronephrosis), and additional evaluations (bladder volume, residual urine 
after voiding, fibrosis of the renal pelvis); final evaluations includes multiple measurements for the calculation 
of a final severity score.” 11 Based on the nomenclature of previous POCUS techniques13 we called named 
our protocol:it “Focused Assessment with Sonography for Urinary Schistosomiasis” (FASUS). The emphasis 
in our selection of criteria was on identification of bladder wall pathology as well as renal pelvis and ureter 
dilatation, assumedwas on image acquisition and interpretation,  to be feasible for operators without 
previouswith little or no previous ultrasound experience, but adequate to make a diagnosis of likely UGS- 
related pathology; more sophisticated procedures such as measurement of bladder volume were omitted, as 
well as complex severity grading scores.. . The initial protocol comprised a transverse scan of the bladder 
and a longitudinal and transverse scan of both kidneys. During the course of the study a longitudinal bladder 
scan was added, given the potential added value in detection of bladder dome pathology. Abnormalities 
compatible with UGS were defined as any bladder wall thickening ≥ 5mm, as in the Niamey criteria, or 
bladder wall calcification, regardless of kidney and ureter findings. be d to be littlerelevance Abnormalities of 
the kidneys and ureters without bladder pathology were not considered compatible with UGS, as this is a 
highly uncommon finding and etiologies other than UGS are more likely..  A description of FASUS probe 
positions in FASUS is presented in Figure 1. The scan planes and documented variables are presented in 
Table 1. Examples of target pathologies are presented in Figure 2. 
Training 
Two operators, a clinician (JR) and a medical student (AV) with little and no previous ultrasound experience 
respectively, were trained on site. The training took around 20 hours overall and included a theoretical part 
(study of ultrasound literature20 and study of the FASUS protocol) followed by a practical part comprising five 
test scans in healthy volunteers per operator. Still images and video clips recorded during the five test scans 
were independently and remotely reviewed by two experts, a paediatric infectious diseases clinician with four 
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years (SB) and a clinical radiologist with over 20 years of ultrasound experience (EJ). Detailed feedback on 
image quality and visualization of target structures was provided, along with practical advice for improvement 
of technique. AV was additionally trained by JR on site.  
Prospective evaluation of the protocol 
Participants of all ages were recruited by convenience sampling in areas of Lambaréné identified as hotspots 
for UGS in previous studies.16, 17 Inclusion criteria wasere history of,previous or ongoing macro-haematuria, 
exclusion criterion was known disease of the urinary tract related to causes other than UGS. Convenience 
sampling was considered appropriate, as this was not intended as a prevalence survey, but as a cohort of 
patients with clinical symptoms. After an initial clinical assessment, FASUS and urine collection for 
parasitology were performed. Following praziquantel treatment, active follow up visits were attempted after 
one and three months.  
Clinical and laboratory procedures 
Clinical assessment consisted of a questionnaire on present or previous symptoms of UGS, known bladder 
or kidney disease, previous praziquantel treatment, duration of fresh water contact and pregnancy. Three 
urine samples provided between 10 a.m. and 2 p.m. on three consecutive days were requested. Semi-
quantitative urine dipstick testing as well as urine filtration (10 ml urine) for microscopy for presence of S. 
haematobium eggs were performed (Dipstick: Combur 10 Test®, Roche Diagnostics Ltd, Risch, Switzerland; 
Millipore filter: Nuclepore Track-Etch Membrane Filtration Products, Whatman plc, Maidstone, UK; 
microscope: Eclipse E200MV R, Nikon, Tokyo, Japan). A positive result was defined as any detection of 
eggs in the filtered urine. Heavy intensity infection was defined as ≥ 50 eggs/10 ml urine.21 In addition, 10ml 
of urine were centrifuged for five minutes at 710 x g and after discarding of the supernatant, 500µl of urine 
was stored at -20°C for Schistosoma genus PCR. In case of negative microscopy, urine real-time PCR for 
Schistosoma-specific DNA was performed at CERMEL as reported previously.22 
Treatment and follow up 
Patients with confirmed urogenital schistosomiasis by at least one urine sample or by FASUS expert 
interpretation were treated with a single dose of praziquantel (40mg/kg). If non-UGS-related pathology was 
found in the FASUS exam, the participant was referred for further management. 
Follow up (FU) visits took place one (M1) and three (M3) months after treatment. Procedures performed 
during follow up comprised a clinical investigation, urine analysis by dipstick, and microscopy. Patients with 
FASUS findings suggestive of UGS at enrolment underwent a follow up scan, reviewed and documented 
similar to enrolment, but using a slightly shorter report form. In case of persistent signs of urinary tract 
pathology at M3, retreatment with praziquantel was provided. If advanced UGS-related pathology was not 
responsive to treatment, the participant was referred to urologic care in the capital for further management. 
Focused assessment with sonography for urinary schistosomiasis (FASUS) 
FASUS scans were performed and evaluated by one of the two operators (Table 1). FASUS videoclips and 
images were stored and remotely reviewed and independently interpreted by two ultrasound experts (SB and 
EJ). This reference test was chosen because cystoscopic evaluation of the bladder as gold standard would 
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not have been medically nor ethically justified, and a locally performed expert reference scan was not 
feasible in the absence of experts. 
A portable low-cost ultrasound device (MINDRAY Digital Ultrasonic Diagnostic Imaging System model DP-
10) with a curved array transducer (MINDRAY model 35C50EB) was used for training as well as for study 
procedures 
. Participants underwent FASUS examination either at their homes or at CERMEL following standardized 
scanning conditions (same ultrasound equipment, patients in supine position, dreclined on examination 
couch or bed, room darkened room, operator seated on the patient’s right side). FASUS at enrolment was 
performed by operator one (JR) and all follow up scans by operator two (AV). A darkened room and 
Ssufficient bladder filling, defined as complete distention of the bladder, wasere attempted as a precondition 
to the exam. Anonymized patient data and ultrasound findings were documented on a clinical record form. 
Images were stored as digital video clips (AVI format) on the ultrasound device; if pathology was suspected, 
additional still images (JPEG format) were stored. Anonymized data were transferred to an external hard 
drive, compressed using the open source video transcoder “HandBrake” (https://handbrake.fr) and bundled 
into zip files using the program “7zip” (http://www.7-zip.org), in order to reduce file size for upload. Zip files 
were uploaded to the secure teleradiology platform “Collegium Telemedicus“ 
(https://collegiumtelemedicus.org) together with basic clinical data (age, sex, current complaints, history). 
All images were independently reviewed by the two experts, blinded to the operators’ findings and laboratory 
data. Review criteria included the diagnostic quality of the scan (overall image quality, depth, gain, focus, 
anatomical orientation, sufficient bladder filling) as well as the presence of pathology as presented in Error! 
Reference source not found.. The experts documented their findings in an anonymized digital PDF report 
form. Any discrepant reading between the reviewers was resolved by consensus. For pragmatic purposes, 
discrepancies in the severity grading of bladder wall pathology were not resolved and only the expert 
findings of the radiologist EJ are presented here. 
Analysis 
Data was entered into OpenClinica (OpenClinica® version 3.0.4, Boston, USA). Data analysis was 





Between December 2015 and June 2016, 119 participants were enrolled. One patient withdrew consent after 
enrolment. The cohort comprised 27 (23%) pre-school age children (PSAC, age < 6 years), 56 (47%) school-
age children (SAC, 6-15 years) and 35 (30%) adults (> 15 years); 56/118 (47%) were female. Microscopic 
haematuria on dipstick was present in 103/118 (87%) patients. Urine microscopy was positive for S. 
haematobium in 105/118 (89%) patients; 69/118 (58%) patients were heavily infected. S. haematobium PCR 
was negative in all 13 patients with negative microscopy. M1 follow up was done for a total of 70/118 (59%) 
patients, M3 follow up was done for a total of 82/118 (69%) patients. Age and gender distribution of the 
follow up cohort was comparable to the entire study population. 
Image quality 
Of a total of 224 FASUS scans, 178 (79%) were performed at the patients’ residence and 46 (21%) at 
CERMEL. The proportion of views considered of sufficient quality for diagnostic interpretation is presented in 
Table 2. Quality of bladder views was sufficient in 22/27 (81%) PSAC, 54/56 (96%) SAC and 31/35 (89%) 
adults. Image depth, gain and focus were rated as good in 99%, 98% and 98% of all scans, respectively. 
The bladder was entirely displayed in 95% of the recorded sweeps. Bladder filling was judged sufficient in 
86%; in 7 out of 11 bladder scans with insufficient quality, the bladder was underfilled. Anatomical orientation 
of the kidney scans was good in 92% with the recorded sweep displaying the renal pelvis in 99%.  
Ultrasound findings 
Pathological features compatible with UGS among baseline scans of sufficient quality were documented in 
51/118 (43%) of cases by the operator and in 46/107 (43%) by the experts, respectively. Frequencies of 
UGS-related pathologies at baseline by operator and expert are presented in Figure 3. Detection rates of 
bladder wall pathology, kidney pelvis and proximal ureter dilatation were similar between operator and 
experts; , while distal ureter dilatation or thickening was detected 3 times as often -folds more by the experts 
than by the operator. Frequencies of UGS-related pathologies  at baseline as assessed by the experts in 
relation to parasitology results are presented in Figure 4. With increasing intensity of infection, bladder and 
upper urinary tract pathology was more frequently detected. 
Taking expert findings as the gold standard, the operators missed features compatible with UGS in 21/202 
(10%) cases and documentedoverdiagnosed false positivefeatures compatible with UGS  FASUS in 9/202 
(4%). Sensitivities and specificities of operator FASUS against the reference standard of a remote expert 
review are presented in Table 3.  
The highest agreement between operator and expert was seen in renal pelvis dilatation, followed by bladder 
wall thickening ≥ 5mm and proximal ureter dilation. For distal ureter pathology agreement was lowest for 
both operators; inter-rater agreement expressed as Cohen’s Kappa is presented in Table 3. 
The development of image quality, diagnostic accuracy and inter-rater agreement with increasing number of 
scans is presented in Figure 5 for each operator. 
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Among 85 cases assessed by both transverse and longitudinal bladder scan, pathology compatible with 
UGS was detected in 35 (41%) by transverse scan alone compared to 38 (45%) by a combination of both 
scans.  
In five cases, renal pelvis and/or ureter dilatation was present without bladder wall thickening ≥ 5mm. One of 
these was pregnant, in three others bladder wall irregularities were present. All five were positive for S. 
haematobium in urine microscopy. 
Pathology not related to UGS was detected in 1/118 (1%) patients by the operators and in 9/118 (8%) 
patients by the experts and comprised free fluid in the pelvis (n = 3), non-specific kidney lesions (n = 2), 
pregnancy-related hydronephrosis, a urachal remnant, non-specific uterine lesions and non-specific strands 
in the bladder (one case each). 
During follow up, pathology compatible with UGS was present in 15/46 (33%) cases at M1 and in 16/49 
(33%) cases at M3 among scans with sufficient quality. Hydronephrosis was present in 3/51 (6%) and 3/54 
(6%) at M1 and M3, respectively. As criteria for follow up were not consistent, these rates cannot be used to 




This pilot diagnostic accuracy study was the first to evaluate a POCUS protocol for the detection of UGS-
related pathology of the urinary tract in symptomatic patients living in a high-endemic area. It showed that 
POCUS operators with limited training can detect such pathology with high diagnostic accuracy, compared to 
expert ultrasound operators; inter-rater -agreement between operator and expert was good for the detection 
of bladder wall pathology and very good for hydronephrosis. Image quality was sufficient in more than 88% 
of all scans. 
Protocol design 
In our protocol, pathology compatible with UGS was defined as bladder wall thickening ≥ 5mm. This cut-off 
was chosen, based on existing Niamey criteria.   However, in many cases bladder wall irregularities < 5mm 
were detected, suggesting indicating that less advanced pathology,  also compatible with UGS, can also be 
detected with current equipment. and short focused training.. This finding may be of value, as earlier 
detection of morbidity may influence management decisions.  Differentiation of bladder wall irregularities 
from a normal bladder wall remains challenging as illustrated by Figure 2 and reported by other studies.12 
Therefore, a threshold of 5 mm appears sensible to limit false positive cases. To keep the protocol as simple 
as possibleas pragmatic as possible for use in the clinical setting, a classification of pathology severity, 
combining bladder and upper urinary tract pathology, as applied in other studies,5, 23 was not used. However, 
as upper urinary tract pathology with concurrent bladder wall irregularities less than< 5mm is also likely to be 
due to UGS (though classified as “not compatible with UGS” in our study), this approach needs to be 
reconsideredreconsidered in larger validation studies..  
As expected, the operators detected fewer abnormalities not related to UGS. The aim of POCUS is to 
answer a very specific clinical question, in this case: "are there findings compatible with UGS", and not to 
provide a comprehensive ultrasound examination or to exclude the presence of other pathology. 
While the Niamey Protocol11 comprises only a transverse view of the bladder, we added a longitudinal 
bladder view assuming a higher sensitivity for detection of pathology especially at the bladder dome. With 
three additional cases of bladder pathology detected by the additional longitudinal view, a gain in sensitivity 
was observedwe recommend including this view in further evaluations of this protocol. Further studies with 
larger sample sizes are required to externally validate our results. A possible future approach could be that 
when a transverse scan does not show any pathology, a longitudinal scan should be performed in addition. 
Training 
During training and study data collection, the team was repeatedly approached by local health care staff 
willing to learn the method, showing the general interest in the achievement of ultrasound skills among local 
clinicians. 
Remote training support and image assessment proved effective to attain good image quality, but as it 
comprised only scans in healthy volunteers, identification of pathology could be learnt in theory only. An e-
learning module with quiz-like character could resolve this deficit. Although remote feedback was given for 
study patient scans as well, it was staggered and therefore time-delayed. The optimal number of training 
scans for FASUS needs to be determined; a broad spectrum of training requirements for point-of-care 
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ultrasound protocols, ranging from a few hours to several days, has been proposed depending on 
sonographic complexity and previous ultrasound knowledge.24-26 
Image quality 
Overall image quality was very good with more than 90% of bladder walls and more than 97% of kidneys and 
proximal ureters being assessable by the expert. Display of distal ureters was slightly more challenging. The 
high expert ratings on gain, depths and focus settings show the effectiveness of the chosen remote training 
model. 
Image quality was best among school-children, due to excellent display of deep anatomic structures related 
to smaller size. Inferior quality among pre-school children and some adults can be explained by limited 
compliance and additional body fat, respectively. 
Interestingly, only two kidney scans and no bladder scans were rated as “unable to assess” by operator one, 
and only two bladders and one kidney scan by operator two, showing that the operators attempted to make 
assessments, despite limitations in image quality. This is a potential source of error and future training 
should emphasize this risk. 
As reported in other studies,12 sufficient bladder filling is crucial for the quality of bladder scans. In the 
absence of a definition or measurement for sufficient bladder filling, in our study insufficient bladder filling 
was judged by eyeballing bladder content and wall. For future application of FASUS, a clear definition of 
sufficient or insufficient bladder filling would be valuable; however, including measurements of bladder 
volumes for age-related normal ranges would considerably increase complexity of the so far simple protocol. 
Definitely, theLearning the critical point of insufficient bladder filling needs to be part of FASUS trainings. 
Diagnostic Aaccuracy  of pilot operators, compared to experts: 
Overall, the diagnostic accuracy of FASUS, performed by our pilot operators, was good for the detection of 
bladder wall thickening ≥ 5mm and very good for the detection of hydronephrosis. Accuracy for the detection 
of ureter pathology was lower, with 8/10 and 5/6 cases of distal ureter pathology missed by the two 
operators, respectively. As all cases of distal ureter pathology occurred together with bladder wall pathology, 
the additional diagnostic value of distal ureter assessment needs to be questioned. Considering its difficulty, 
it should rather be omitted from the protocol. 
While image quality and sensitivity  improved for both operators over the course of the study, there was a 
slight decline in specificity. Although conclusions need to be drawn with caution due to the small sample 
size, this might point at a shift from underestimation to overestimation of pathology with increasing number of 
scans.  
In another study on the learning curve of the, more complicated, Niamey protocol for prevalence surveys, by 
Bonnard et al., sensitivity and specificity of the learner in comparison to the teacher had both reached 100% 
after 5 days and 91 examinations.27 However, the teacher directly supervised the learner, in contrast to the 
staggered remote feedback over the period of around three months per operator in our study. Furthermore, 
the authors left unclear whether the learning clinician had previous ultrasound experience. TwoFew other 
studies on remotely reviewed POCUS in tropical medicine describing the detection of extra-pulmonary TB 
provided a diagnostic  accuracy sensitivity and specificity of the operator compared to the expert that was 
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comparable to our study.28, 29 However, unlike with our approach, exams were transmitted and assessed 
remotely in real-time and not via saved video clips, limiting comparison. 
As urinary tract pathology increased with increasing intensity of infection in this as well as other studies,30 an 
algorithm that combines parasitological with ultrasonographic findings, especially in patients with heavy 
intensity of infection, could maximize diagnostic accuracy. 
Overall, the learning of this POCUS technique via remote review and feedback appears to be feasible and 
leads to good diagnostic accuracy that can be maintained over longer periods. 
Of note, As recruitment was done via convenience sampling, as the intention of this study was not to identify 
infection rates, the reported rate of UGS-related pathology among the study population does not reflect that 
in the general population in Gabon. 
Management of pathological findings 
As sonographic detection of UGS-related pathology has mostly been used in the evaluation of large-scale 
control programs, no algorithms for individual patient management based on ultrasound are available. 
FASUS could help in the identification of at-risk patients in need of regular follow up and re-treatment, in 
areas where regular preventive treatment is not indicated or insufficiently implemented. Patients with 
advanced pathology such as therapy resistant hydronephrosis or suspicious bladder lesions could be 
referred for further diagnostics and management, where available. 
Limitations 
As a pilot study, the protocol underwent changes during the course of the study, thus parts of the data are 
incomplete. As recruitment was done via convenience sampling, the rate of UGS-related pathology among 
the study population does not reflect that in the general population in Gabon. 
Our reference test of a remote expert review is inferior to a locally performed expert reference scan, but was 
the best and only feasible option in the absence of local expertise. With only quality-reduced CINE clips and 
still images as a basis for the interpretation, pathology might have been missed by the experts or normal 
findings and artefacts mistaken for pathology. However, this telemedicine-based training and image review 
design provides a feasible model for pilot studies of novel indications for POCUS training in resource-limited 
settings, where no alternative options exist. 
Conclusions 
FASUS is a promising bedside diagnostic tool with good diagnostic accuracy in this pilot assessmentfor 
detection of UGS- related morbidity in symptomatic patients living in high-endemic areas. Simple protocols 
and short training appear adequate and feasible, despite the common limitations present in a low resource 
setting, such as novice clinician trainees, low-budget ultrasound devices, and examinations performed in the 
field. If further validation studies confirm the utility of FASUS, internationally agreeable standards for training 
and competency duration, contents and intensity should be set. Based on data from larger cohorts examined 
with FASUS in future studies, appropriate diagnostic and therapeutic algorithms for its use in routine patient 
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Figure 1: FASUS probe positions 
1 and 2: Transverse and longitudinal suprapubic pelvis scan. 
3 and 4: Longitudinal and transverse right kidney scan. 
5 and 6: Longitudinal and transverse left kidney scan. 
 
Figure 2: Examples of target pathologies detected by FASUS 
 
Figure 3: Pathology detected by FASUS at baseline by operator and expert  
NA: not available. 
 
Figure 4: Pathology detected by FASUS at baseline (expert review) in relation to parasitology 
a Urine microscopy and PCR. 
b Renal pelvis dilatation > 1cm, proximal ureter dilatation or distal ureter dilatation/thickening. 
 
Figure 5: Operator improvement in bladder wall assessment 
a Image quality of bladder scans sufficient for expert interpretation. 
b Ultrasound operator findings compared to expert consensus after remote review of recorded clips. 
Table 1: FASUS protocol 
 
a Any of b), c) or d) was defined as pathology compatible with urogenital schistosomiasis. 
b Added to the protocol after recruitment of 45 cases because a higher sensitivity in the detection of 
bladder wall thickening was assumed. 
 
 




1) Transverse Bladder wall 
Distal ureters 
a) Bladder wall irregularities < 5 mm thickness 
b) Wall thickening 5 – 10 mm 
c) Maximum thickening, masses or pseudopolyps  
≥ 10 mm 
d) Bladder wall calcification 
e) Distal ureter dilatation or thickening 
f) Findings not related to urogenital schistosomiasis 
2) Longitudinalb Bladder wall 
Distal ureters 
Kidneys (right and left) 
1) Longitudinal Proximal ureter and 
collecting system 
g) Proximal ureter dilatation 
h) Findings not related to urogenital schistosomiasis 
2) Transverse Renal pelvis  i) Renal pelvis dilatation (> 1cm) 
 If abnormal, confirmed after bladder voiding 
j) Findings not related to urogenital schistosomiasis 
Table 1
Table 2: Ultrasound image quality sufficient for expert interpretation 















































a Combination of transverse and longitudinal scan, when available. 
b Baseline scans performed by operator one, follow up scans performed by operator two. 
c For distal ureter views at baseline: n = 114. 
Table 2
Table 1: Accuracy of newly trained operators, compared to expert ultrasound opinionDiagnostic 
accuracy of FASUS 
 
a Ultrasound operator findings compared to expert consensus after remote review of recorded clips. 
b If confirmed after bladder voiding, or if severe. 
c Baseline scans performed by operator one, follow up scans performed by operator two. 












dilatation > 1cmb 
Operatorc 1 2 1 2 1 2 1 2 
Total scansd 107 95 87 93 111 102 110 104 
Sensitivity (%) 83 68 17 23 57 50 100 83 
Specificity (%) 90 95 97 99 100 95 98 100 
Observed inter-
rater agreement 
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To: 
Professor Sir Brian Greenwood 
Editor-in-chief 









Subject: Revision of the article “Focused Assessment with Sonography for Urinary 
Schistosomiasis (FASUS) – pilot evaluation of a simple point-of-care ultrasound protocol and 
short training program for detecting urinary tract morbidity in highly endemic settings” 
(TRSTMH-D-19-00077) 
 
Dear Professor Joshi, 
Thank you very much for inviting us to revise our manuscript previously titled Focused Assessment 
with Sonography for Urinary Schistosomiasis (FASUS) – diagnostic accuracy of a simple protocol to 
detect urinary tract morbidity in resource-limited settings. We thank the reviewers for their constructive 
comments which we have addressed point-by-point below. 
We also appreciate that the reviewer's comments have highlighted the fact that we have not 
emphasized clearly enough that this is a pilot study to assess a potential role for bedside ultrasound 
as a clinical tool, not intended for use in epidemiological surveys. In addition to addressing the 
reviewers’ comments, we have therefore altered the introduction and title accordingly. 
Thank you very much. 
Yours sincerely 










The authors have highlighted some limitations of the study such as the small sample size, 
representativeness of Gabon population and the gold standard used to assess the diagnosis 
accuracy. However, they have to address how they controlled such limitations. For e.g., they should 
have compared the baseline sociodemographic and economic characteristics of the study participants 
to the general population from the study area (Demographic health survey?). That could help to 
assess the representativeness of the study population. 
 
Answer: 
We agree that if the representativeness of the study population is mentioned as limitation of the study, 
measures on controlling this limitation should be further addressed in the manuscript. The focus of this 
manuscript was to pilot the diagnostic performance of the novel ultrasound approach in a clinical 
setting (ultrasound naïve operator versus ultrasound expert) and not on epidemiological questions. 
Therefore, by reappraising the section on limitations of our study we think that the respective sentence 
“As recruitment was done via convenience sampling, the rate of UGS-related pathology among the 
study population does not reflect that in the general population in Gabon.” is not appropriately placed 
within the limitations section. To avoid misunderstanding on the epidemiologic situation in Gabon, we 
do however think it is important to make clear to the reader that the rate of findings cannot reflect that 
in the general population. We therefore moved the respective sentence to the end of the “diagnostic 
accuracy” section of the discussion. 
 
Changes (page 12, paragraph 6): 
The following sentence was removed: “As recruitment was done via convenience sampling, the rate of 
UGS-related pathology among the study population does not reflect that in the general population in 
Gabon.” 
 
Changes (page 12, paragraph 4): 
We added the following sentence “Of note, as the intention of this study was not to identify infection 
rates, the reported rate of UGS-related pathology among the study population does not reflect that in 
the general population in Gabon.” 
 
Comment 2 
By reading the paper, it seems that the authors have more assessed the reliability of the focused 
assessment with Sonography for urinary schistosomiasis (FASUS) than the diagnosis accuracy. They 
should be more clear about what kind of assessment they made (reliability, accuracy or both). As well, 
whatever the assessment, they should give more precision such as positive, negative predictive 
values for assessing diagnosis accuracy. 
 
Answer: 
We thank the reviewer for this important comment. After reappraisal of our study design, we agree that 
it is not suitable for the assessment of the diagnostic accuracy of FASUS itself. By the selection of our 
inclusion criteria (previous or ongoing macro-haematuria) and enrolment via convenience sampling, 
we have instead evaluated whether FASUS enables previously untrained operators to detect UGS-
related urinary tract pathology in the clinical setting of a symptomatic patient. As this aspect is of major 
importance for the correct understanding of our paper, we have modified several paragraphs 
throughout the manuscript and also changed the title of our study. 
For similar reasons, our investigations do not allow a valid calculation of positive and negative 
predictive values (PPV and NPV) of FASUS, although we agree that their assessment would be very 
important in connection with the diagnostic accuracy of FASUS. The PPV and NPV depend on the 
prevalence of the assessed pathology and are not intrinsic to the test. Because of the preselection of 
our study population the reported prevalence of pathological finding cannot be compared to the 
prevalence among the general population. Future studies that perform FASUS on a representative 
sample of the general population will be suitable for calculation of the PPV and NPV. 
 
Changes (page 1, title): 
The title was changed from: “Focused Assessment with Sonography for Urinary Schistosomiasis 
(FASUS) – diagnostic accuracy of a simple protocol to detect urinary tract morbidity in resource-limited 
settings” to “Focused Assessment with Sonography for Urinary Schistosomiasis (FASUS) – pilot 
evaluation of a simple point-of-care ultrasound protocol and short training program for detecting 
urinary tract morbidity in highly endemic settings.” 
 
Changes (page 2, paragraph 4): 
In the conclusions section of the abstract we changed the sentence “FASUS is a promising bedside 
diagnostic tool with good diagnostic accuracy in this pilot assessment.” to “FASUS is a promising 
clinical, point-of-care tool for detecting USG related renal tract morbidity in symptomatic patients.” 
 
Changes (page 3, last paragraph): 
In the introduction section we changed the sentence “The aim of our study was to develop a POCUS 
protocol for UGS-related morbidity and to evaluate its feasibility and accuracy after limited training of 
operators using low-cost equipment” to “The aim of our study was to pilot a POCUS protocol for 
detection of UGS-related renal tract morbidity in symptomatic patients, to evaluate practical feasibility 
and evaluate the performance of operators with limited training, using low cost equipment” 
 
Changes (page 4, paragraph 1): 
In the methods section we changed the sentence “evaluation of the diagnostic accuracy of this 
protocol in patients with UGS with remote expert image review as reference” to “evaluation of the 
diagnostic accuracy of POCUS operators, using remote expert image review as reference”. 
 
Changes (page 6, paragraph 2): 
We added the following sentence “Convenience sampling was considered appropriate, as this was not 
intended as a prevalence survey, but as a cohort of patients with clinical symptoms”. 
 
Changes (page 10, paragraph 1): 
In the discussion section we changed the sentence “This pilot diagnostic accuracy study was the first 
to evaluate a POCUS protocol for the detection of UGS-related pathology of the urinary tract. It 
showed that POCUS operators with limited training can detect such pathology with high diagnostic 
accuracy” to “This pilot study was the first to evaluate a POCUS protocol for the detection of UGS-
related pathology of the urinary tract in symptomatic patients living in a high-endemic area. It showed 
that POCUS operators with limited training can detect such pathology with high accuracy, compared to 
expert ultrasound operators” 
 
Changes (page 11, paragraph 6): 
In the discussion section we changed the subheading “Diagnostic accuracy” to “Accuracy of pilot 
operators, compared to experts”. The subsequent sentence “Overall, the diagnostic accuracy of 
FASUS was …” was changed to “Overall, the accuracy of FASUS, performed by our pilot operators, 
was …” 
 
Changes (page 11, last paragraph): 
We changed the sentence “In another study on the learning curve of the Niamey protocol by Bonnard 
et al., sensitivity and specificity had …” to “In another study on the learning curve of the more 
complicated Niamey protocol for prevalence surveys by Bonnard et al., sensitivity and specificity of the 
learner in comparison to the teacher had …” 
 
Changes (page 12, paragraph 3): 
In the sentence “Overall, the learning of this POCUS technique via remote review and feedback 
appears to be feasible and leads to good diagnostic accuracy that can be maintained over longer 
periods” we removed the word “diagnostic”. 
 
Changes (page 12, last paragraph): 
In the conclusions section we changed the sentence “FASUS is a promising bedside diagnostic tool 
with good diagnostic accuracy in this pilot assessment” to “FASUS is a promising bedside diagnostic 
tool for detection of UGS-related morbidity in symptomatic patients living in high endemic areas”. 
 
Changes (Table 3): 
The title of Table 3 was changed from “Diagnostic accuracy of FASUS” to “Accuracy of newly trained 
operators, compared to expert ultrasound opinion”. 
In the upper left cell of the table, we changed “Diagnostic accuracy” into “Accuracy”. 
 
Comment 3 
The reliability (reproducibility) is often measured by the use of the Kappa coefficient which adjusts the 
observed agreement for expected chance agreement. The authors should provide in a table the 
observed agreement and not only the Kappa coefficient. As well, the reliability of a diagnostic test 
depends on the accuracy and reproducibility of the results. Both the predictive values and the Kappa 
coefficient are supposed to depend on the prevalence and this should be noticed when the results of 
different studies are compared. 
 
Answer: 
We agree that when reporting on reliability of our test the observed agreement should be reported in 
addition to the Kappa coefficient to provide sufficient information for the reader. We therefore added 
the observed agreement between each operator and the experts for the respective pathology 
variables to our Table 3. 
We also agree that Kappa scores cannot be compared between our study and the studies cited as the 
prevalence of the assessed pathology differed among the study populations. We therefore specified in 
our paper that only sensitivity and specificity were comparable to our study. 
 
Changes (Table 3): 
We added a row to table 3 labelled “Observed inter-rater agreement” that lists the observed 
agreement factors for each variable. The label of the row below was changed from “Inter-rater 
agreement (Cohen’s Kappa)” to “Cohen’s Kappa”. 
 
Changes (page 11, last paragraph): 
We changed the sentence “Few other studies on remotely reviewed POCUS in tropical medicine 
describing the detection of extra-pulmonary TB provided a diagnostic accuracy comparable to our 
study” to “Two other studies on remotely reviewed POCUS in tropical medicine describing the 
detection of extra-pulmonary TB provided a sensitivity and specificity of the operator compared to the 
expert that was comparable to our study” 
 
Comment 4 
Ethical statement session is missing 
 
Answer: 
The ethical statement is given in the authors’ statements (page 13): “Ethical approval: This study was 
approved by the scientific review committee and the institutional ethics committee of CERMEL. Written 






4th paragraph: Now that point-of-care…….settings…. Please give a reference for this statement. 
 
Answer: 
Other applications of POCUS in tropical medicine such as POCUS for HIV-associated tuberculosis 
and echinococcosis are already listed in in the same paragraph with the review by Bélard et al. as 
reference (reference nr. 13). We therefore removed the sentence from the manuscript. 
 
Changes (page 3, last paragraph): 
We removed the sentences “Now that point-of-care ultrasound (POCUS) is expanding rapidly in 
resource constrained settings, a simplified and more pragmatic protocol to identify relevant pathology 
may be of value to establish the clinical diagnosis, assess urinary tract damage, guide appropriate 




Comment 6, protocol development 
Comment 6.1:  
Please, provide a reference for the nomenclature of previous POCUS techniques. 
 
Answer: 
As the before mentioned and cited review of Bélard et al. Am J Trop Med Hyg, 2016 discusses a 
number of available POCUS modules (FAST (focused assessment with sonography for trauma), 
FASH (focused assessment with sonography for HIV-associated tuberculosis), FASE (focused 
assessment with sonography for echinococcosis)) applying a nomenclature consistent with the 
abbreviation FASUS, we added this reference to this statement. 
 
Changes (page 5, paragraph 2): 
“Based on the nomenclature of previous POCUS techniques13 we named our protocol “Focused 
Assessment with Sonography for Urinary Schistosomiasis” (FASUS).” 
 
Comment 6.2:  
Describe shortly the Niamey protocol. 
 
Answer and changes (page 5, paragraph 2): 
As suggested by the reviewer we shortly summarized the Niamey protocol in the methods section. We 
therefore changed the sentence “A simple and easy-to-learn protocol was designed by the study team 
adapted from the Niamey protocol” to  “A simple and easy-to-learn protocol was designed by the study 
team, selecting clinically relevant criteria  adapted from the Niamey protocol, which provides standards 
for the evaluation of the urinary bladder (shape, bladder wall thickening, irregularities and polyps), 
ureters (ureteral dilation), renal pelvis (degree of hydronephrosis), and additional evaluations (bladder 
volume, residual urine after voiding, fibrosis of the renal pelvis); final evaluations includes multiple 
measurements for the calculation of a final severity score.11” 
 
Comment 6.3:  
Authors should give more details concerning the threshold of bladder wall thickening > 5mm. 
 
Answer: 
The threshold of 5 mm originates from the Niamey protocol. We therefore chose the same criteria 
initially while designing the study. During our study we observed that operators and equipment could 
actually detect more subtle pathology. Further considerations on the definition of pathology compatible 
with UGS are discussed in the discussion section (page 10, paragraph 2). 
 
Changes (page 10, paragraph 2): 
We added the sentence “This cut-off was chosen, based on existing Niamey criteria.” The following 
sentence was changed from “However, in many cases bladder wall irregularities < 5mm were 
detected, suggesting less advanced pathology also compatible with UGS” to “However, in many cases 
bladder wall irregularities < 5mm were detected, indicating that less advanced pathology, compatible 
with UGS, can also be detected with current equipment. and short focused training. This finding may 
be of value, as earlier detection of morbidity may influence management decisions” 
 
Comment 7: Training 
Comment 7.1: 
The two operators (JR & AV) have a different level of knowledge (medical student & a clinician). Why 




Within our study setting and frame it was not feasible to acquire two operators of exactly the same 
level of experience. POCUS techniques are supposed and designed to be operational by operators 
with different levels of experience and feasible. We therefore think that a bias by the operators’ level of 
clinical experience is unlikely. 
 
Comment 7.2: 
The authors highlighted that AV was additionally trained by JR on site. The authors should explain why 
because this could lead a bias in the accuracy assessment. 
 
Answer and changes (page 6, first paragraph): 
Thank you for highlighting this aspect, as the sentence might indeed lead to confusion. As local 
principal investigator JR was involved in the study design; he trained AV on all study related aspects 
beyond the performance of FASUS (study flow, taking informed consent, collection of clinical and 
parasitological data, documentation, upload of records etc.). The specific training of FASUS was the 
same for JR and AV and performed as described in the methods section. To avoid confusion we 
therefore removed the sentence “AV was additionally trained by JR on site”. 
 
Comment 8: prospective evaluation 
The study participants have been followed-up after praziquantel treatment after one and three months. 
Why 3 months of follow-up? Is it enough for assessing morbidity? If yes, give the reasons. 
 
Answer: 
Longitudinal studies (Jukiko et al, JID, 1999; Hatz et al, Am J Trop Med Hyg, 1998) have observed a 
marked decrease in the occurrence of bladder pathology one month and a further decrease three 
months after treatment. After three months, no further reduction of pathology was noted and there was 
an increasing rate of pathology reappearance. 
 
Comment 9 
Analysis: Any sample size calculation? If not, any power calculation with the study sample?  
 
Answer: 
We performed a sample size calculation during the development of the study protocol setting 95% 
confidence and 80% power to detect a difference in discordance of 10% below which the new 
diagnostic test is non-inferior to the reference standard and yielded a sample size of at least 116 
patients. This calculation must however be understood as an estimate, since our study is a pilot and 
mainly intended to inform larger studies, including their sample sizes. 
 
Comment 10: results 
Comment 10.1: 
The cohort attrition seems to be high; 41% of loss of follow-up at M1 and 31% at M3. The authors 
have to compare the characteristics of participants who completed the study and those who did not. 
 
Answer and changes (page 8, paragraph 1): 
Thank you for indicating this aspect. We added the following sentence to the manuscript: 
“Age and gender distribution of the follow up cohort was comparable to the entire study population”. 
 
Comment 10.2: 
Image quality: Why different place of assessment (Home and hospital)? The authors should have 
discussed that could not have affected the diagnosis accuracy. 
 
Answer: 
The reason why parts of the ultrasound assessments were performed at the patients’ residence and 
parts at the CERMEL was logistical. Following the reviewer’s comment we reappraised the likelihood 
that the place of FASUS may have influenced our data. As scanning conditions were standardized by 
our study standard operating procedure (i.e. same ultrasound equipment, patients in supine position, 
darkened room, operator seated on the patient’s right side) an impact of the place of FASUS 
performance on the data appears unlikely to us.  
 
Changes (page 7, paragraph 3): 
To clarify this, we added the following to the methods section: “… following standardized scanning 
conditions (same ultrasound equipment, patients in supine position, darkened room, operator seated 
on the patient’s right side)”. We changed the sentence “A darkened room and sufficient bladder filling, 
defined as complete distention of the bladder, were attempted …” to “Sufficient bladder filling, defined 
as complete distention of the bladder, was attempted …”. 
 
Comment 11: Ultrasound findings 
Comment 11.1: 
Please, give shorts comments on figure 3 & 4. 
 
Answer and changes (page 8, paragraph 3): 
We added the following sentences to the manuscript: “Detection rates of bladder wall pathology, 
kidney pelvis and proximal ureter dilatation were similar between operator and experts; distal ureter 
dilatation or thickening was detected 3 times as often by expert than by operator.” And: “With 
increasing intensity of infection, bladder and upper urinary tract pathology was more frequently 
detected.” 




Sensitivity and specificity are not enough to assess the diagnosis accuracy. The authors should also 
assess predictive values 
 
Answer: 
We addressed this aspect in our response to your comment 2. 
 
Comment 12: Discussion 
Comment 12.1 
3rd paragraph: ……..a gain in sensitivity was observed. Please, give more information about it, 
especially in the result session. 
 
Answer: 
More details about the additional value of the longitudinal bladder scan are reported in the results 
section on page 9 (first paragraph): “Among 85 cases assessed by both transverse and longitudinal 
bladder scan, pathology compatible with UGS was detected in 35 (41%) by transverse scan alone 
compared to 38 (45%) by a combination of both scans.” 
 
Comment 12.2 
The authors should also discuss the feasibility of this kind of assessment in resource-limited settings. 
 
Answer: 
We think we have addressed this point at several occasions throughout the discussion and conclusion 
with the following statements: 
“During training and study data collection, the team was repeatedly approached by local health care 
staff willing to learn the method, showing the general interest in the achievement of ultrasound skills 
among local clinicians.” 
“Overall, the learning of this POCUS technique via remote review and feedback appears to be feasible 
and leads to good accuracy that can be maintained over longer periods.” 
“However, this telemedicine-based training and image review design provides a feasible model for 
POCUS training in resource-limited settings, where no alternative options exist.” 
“Simple protocols and short training appear adequate and feasible, despite the common limitations 
present in a low resource setting, such as novice clinician trainees, low-budget ultrasound devices, 
and examinations performed in the field.” 
 
 
Reviewer 2:  
 
Thank you for conducting this study to design a protocol for FASUS. 
 
Comment 1 
It would be good to discuss some background on the Niamey protocol and its limitations/need for 
improvement. 
 
Answer and changes (page 3, paragraph 4): 
We thank the reviewer for this comment. We have amended and revised the respective section in the 
introduction as follows: “In 1996 the World Health Organization (WHO) published a standardised 
protocol for the ultrasonographic assessment of schistosomiasis-related morbidity, commonly known 
as the Niamey protocol. However, this protocol is specifically designed for application in large-scale 
control programs and not for diagnosis in the clinical setting. It includes a detailed and relatively 
complex grading system, which is less relevant to clinical application.  Contrary to widespread 
experience of using ultrasound in prevalence surveys, it has not been validated for routine patient care 
in endemic areas. In addition, prevalence surveys mostly rely on operators with professional 
ultrasound training. In many clinical settings, this expertise is lacking.” 
 
Comment 2 
Would a study comparing to the full Niamey protocol be worthwhile to do? It would give some insight 
into how much different the results would be without bladder filling (as the FASUS might also inform 
how the Niamey protocol can be simplified or improved further) 
In my opinion, the gold standard is the Niamey protocol and not expert findings. (page 8/27) 
 
Answer: 
We agree that a study comparing FASUS to the full Niamey protocol would be of great value and 
should be performed. As no expert sonographers were available on-site in our setting, we chose the 
remote expert review of recorded ultrasound clips as reference. Future studies comparing the two 
protocols may indeed inform on how the Niamey protocol can be improved but may also inform on 
how the FASUS protocol can be improved. 
 
Comment 3 
Please also comment on other experts' view to revise the Niamey protocol vis a vis the development 
of the FASUS protocol. 
 
Answer: 
The review of Akpata et al. 2015 (reference number 12 in our manuscript) provides a good insight on 
experts’ views on the Niamey protocol and suggestions for its simplification. We took this review into 
account during the design of the FASUS protocol and followed some suggested propositions by 
modifying the scoring of bladder wall and upper urinary tract pathology. 
 
Additional changes: 
While revising the manuscript, we noticed several sentences in need of revision, independent from the 
reviewers’ comments. The respective modifications are listed below: 
 
Changes (page 2): 
Abstract, background section: 
We changed the sentence “In resource-limited settings, novel diagnostic tools are needed for 
morbidity assessment” to “In resource-limited settings, affordable tools for morbidity assessment in 
clinical care are needed” and the sentence “Point-of-care ultrasound has not yet been investigated on 
the detection of UGS-related pathology” to “Point-of-care ultrasound has not yet been validated for 
UGS-related pathology” 
 
Abstract, methods section: 
We changed the sentence “Recorded ultrasound clips were remotely reviewed by two experts as 
reference” to “Recorded ultrasound clips were remotely reviewed by two ultrasound experts as 
diagnostic reference”. 
 
Abstract, results section: 
We removed the word “FASUS” from the sentence “In 2015 and 2016, FASUS scans were performed 
in 118 patients”. 
 
Abstract, conclusions section: 
We changed the sentence “Based on data from larger cohorts examined with FASUS, appropriate …” 
to “Based on larger validation studies, appropriate …” 
 
Changes (page 3, paragraph 1): 
We added the sentence "In patients with irreversible damage, options for treatment will depend on the 
type of damage and available treatment”. 
 
Changes (page 3, paragraph 3): 
We changed the sentence “Ultrasound is a well-documented, effective imaging tool…” to “In 
prevalence surveys, ultrasound has long been established as an effective imaging tool…”. 
We added the sentence “Being a test for morbidity and not active infection, ultrasound does not 
replace but complement parasitological tests” 
 
Changes (page 4, paragraph 1): 
We removed the sentence “Being a test for morbidity and not active infection, such a protocol will not 
replace but complement parasitological tests” 
 
Changes (page 3, second-to-last paragraph): 
We changed the sentence “POCUS has been successfully…” to “Point-of-care ultrasound has been 
successfully…” 
 
Changes (page 5, paragraph 1): 
We added the following sentence “It was part of a larger study, which additionally assessed 
epidemiological aspects as well as immunological and metabolomic aspects of UGS; these will be 
reported separately.” 
We changed the following sentences “In summary, this study comprised the following parts: A) 
development of an ultrasound protocol for point-of-care detection of UGS-related pathology; B) training 
of two operators on this protocol; C) evaluation of the diagnostic accuracy of this protocol in patients 
with UGS with remote expert image review as reference” to “Procedures relevant for the pilot 
assessment of our POCUS protocol were A) development of a POCUS scan protocol; B) training of 
two operators; C) evaluation of the diagnostic accuracy of POCUS operators, using remote expert 
image review as reference. D) Comparing ultrasound findings with parasitology test results” 
The following sentence was moved to page 7, first paragraph: “A portable low-cost ultrasound device 
(MINDRAY Digital Ultrasonic Diagnostic Imaging System model DP-10) with a curved array transducer 
(MINDRAY model 35C50EB) was used for training as well as for study procedures.” 
 
Changes (page 5, paragraph 2): 
We changed the sentence “The emphasis was on identification of bladder wall pathology as well as 
renal pelvis and ureter dilatation, assumed to be feasible for operators without previous ultrasound 
experience; more sophisticated procedures such as measurement of bladder volume were omitted” to 
“The emphasis in our selection of criteria was on image acquisition and interpretation, feasible for 
operators with little or no previous ultrasound experience, but adequate to make a diagnosis of likely 
UGS-related pathology; more sophisticated procedures such as measurement of bladder volume were 
omitted, as well as complex severity grading scores” 
In the sentence “Abnormalities compatible with UGS were defined as any bladder wall thickening ≥ 
5mm…” we added “as in the Niamey criteria”. 
After the sentence “Abnormalities […] were not considered compatible with UGS” we added “as this is 
a highly uncommon finding and etiologies other than UGS are more likely”. 
In the sentence “FASUS probe positions in FASUS is…” we removed “in FASUS”. 
 
Changes (page 6, paragraph 2): 
We changed the sentence “Inclusion criteria were history of, or …” to “Inclusion criteria was previous 
or …” 
 
Changes (page 8, paragraph 4): 
We changed the sentence “… missed features compatible with UGS in 21/202 (10%) cases and 
documented false positive FASUS in 9/202 (4%).” To “…missed features compatible with UGS in 
21/202 (10%) cases and overdiagnosed features compatible with UGS in 9/202 (4%).” 
 
Changes (page 9, paragraph 3): 
In the sentence “Pathology not related to UGS…” we changed “operator” to “operators” and removed 
“(one case each)”. 
In the sentence “inter-rater agreement between…” we changed “bladder wall” to “bladder wall 
pathology”. 
 
Changes (page 10, paragraph 2): 
We changed the sentence “To keep the protocol as simple as possible a classification of pathology, 
combining…” to “To keep the protocol as pragmatic as possible for use in the clinical setting, a 
classification of pathology severity, combining …” 
We changed the sentence “However, as upper urinary tract pathology with concurrent bladder wall 
irregularities < 5mm is likely to be due to UGS (though classified as “not compatible with UGS” in our 
study), this approach needs to be reconsidered” to “However, as upper urinary tract pathology with 
concurrent bladder wall irregularities less than 5mm is also likely to be due to UGS (though classified 
as “not compatible with UGS” in our study), this approach needs to be reconsidered in larger validation 
studies” 
We added the sentence “As expected, the operators detected fewer abnormalities not related to UGS. 
The aim of POCUS is to answer a very specific clinical question, in this case: ‘are there findings 
compatible with UGS’, and not to provide a comprehensive ultrasound examination or to exclude the 
presence of other pathology.” 
 
Changes (page 10, paragraph 4): 
We changed the sentence “…detected by the additional longitudinal view, a gain in sensitivity was 
observed” to “…detected by the additional longitudinal view, we recommend including this view in 
further evaluations of this protocol”.  
We removed the sentence “Further studies with larger sample sizes are required to externally validate 
our results. A possible future approach could be that when a transverse scan does not show any 
pathology, a longitudinal scan should be performed in addition”. 
 
Changes (page 10, paragraph 5): 
We removed “study” from “study data collection”. 
We added “remote” to “feedback”. 
 
Changes (page 11, paragraph 4): 
After “…only two kidney scans […] were rated as ‘unable to assess’ by operator one…” we added the 
sentence “This is a potential source of error and future training should emphasize this risk”. 
 
Changes (page 11, paragraph 5): 
After the sentence “…increase complexity” We removed “of the so far simple protocol”. 
The next sentence was changed from “Definitely, the critical point …” to “Learning the critical point…”. 
We changed “FASUS trainings” to “FASUS training”. 
 
Changes (page 12, paragraph 7): 
We changed the sentence “However, this telemedicine-based training and image review design 
provides a feasible model for pilot studies of novel indications for POCUS in resource-limited settings” 
to “However, this telemedicine-based training and image review design provides a feasible model for 
POCUS training in resource-limited settings, where no alternative options exists” 
 
Changes (page 12, last paragraph): 
We changed the sentence “internationally agreeable standards for training and duration, contents and 
intensity should be set” to “internationally agreeable standards for training and competency should be 
set”.  
In the next sentence we removed “examined with FASUS in future studies”. 
 
Changes (title of Figure 4): 
The title of Figure 4 was changed from “Pathology detected by FASUS at baseline in relation to 
parasitology” to “Pathology detected by FASUS at baseline (expert review) in relation to parasitology” 
